Cardiac mitochondrial alterations in a mouse model of fabry disease

被引：0
|
作者：
Gambardella, Jessica [1 ]
Sorriento, Daniela [1 ]
Cerasuolo, Federica [1 ]
Perrino, Cinzia [1 ]
Boccella, Nicola [1 ]
Ciccarelli, Michele [2 ]
Valenzano, Ken [3 ]
Iaccarino, Guido [1 ]
机构：
[1] Univ Naples FedericoII, Dept Adv Biomed Sci, Naples, Italy
[2] Univ Salerno, Dept Med & Surg, Salerno, Italy
[3] AmicusTherapeutics, Cranbury, NJ USA
来源：
VASCULAR PHARMACOLOGY | 2020年 / 132卷
关键词：
D O I：
10.1016/j.vph.2020.106721
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease
    Taguchi, Atsumi
    Ishii, Satoshi
    Mikame, Mariko
    Maruyama, Hiroki
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2023, 34
  • [32] Age-dependent substrate accumulation in a mouse model of Fabry disease
    Sturk, L. M.
    Pan, J.
    Zaleski, K.
    Alessandrini, M.
    Neal, C.
    Lamsa, J.
    ACTA PAEDIATRICA, 2008, 97 : 109 - 110
  • [33] Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model
    Jabbarzadeh-Tabrizi, Siamak
    Boutin, Michel
    Day, Taniqua S.
    Taroua, Mouna
    Schiffmann, Raphael
    Auray-Blais, Christiane
    Shen, Jin-Song
    JOURNAL OF LIPID RESEARCH, 2020, 61 (11) : 1410 - 1423
  • [34] Altered Gene Expression in Prefrontal Cortex of a Fabry Disease Mouse Model
    Kummer, Kai K.
    Kalpachidou, Theodora
    Mitric, Miodrag
    Langeslag, Michiel
    Kress, Michaels
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [35] Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease
    Cassano, Tommaso
    Serviddio, Gaetano
    Gaetani, Silvana
    Romano, Adele
    Dipasquale, Pasqua
    Cianci, Silvia
    Bellanti, Francesco
    Laconca, Leonardo
    Romano, Antonino Davide
    Padalino, Iolanda
    LaFerla, Frank M.
    Nicoletti, Ferdinando
    Cuomo, Vincenzo
    Vendemiale, Gianluigi
    NEUROBIOLOGY OF AGING, 2012, 33 (06)
  • [36] Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry Disease
    Orsborne, Christopher
    Bradley, Joshua
    Bonnett, Laura J.
    Pleva, Luke A.
    Naish, Josephine H.
    Clark, David G.
    Abidin, Nik
    Woolfson, Peter
    Nucifora, Gaetano
    Schmitt, Matthias
    Jovanovic, Ana
    Miller, Christopher A.
    Reid, Anna B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (10) : 982 - 994
  • [37] Stroke and brain structural alterations in Fabry disease
    Fellgiebel, Andreas
    CLINICAL THERAPEUTICS, 2007, 29 : S9 - S10
  • [38] Low frequencies of mitochondrial DNA mutations cause cardiac disease in the mouse
    Mott, JL
    Zhang, D
    Farrar, PL
    Chang, SW
    Zassenhaus, HP
    OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 : 353 - 357
  • [39] Myocardial Alterations in the Murine Model of Fabry Disease Can Be Reversed by Enzyme Replacement Therapy
    Rozenfeld, Paula A.
    Fritz, Mariana
    Blanco, Paula
    Gonzalez, Pedro
    Rinaldi, Gustavo J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (03) : 339 - 345
  • [40] The Fabry registry: early cardiac events in Fabry disease patients
    Bultas, J
    EUROPEAN HEART JOURNAL, 2004, 25 : 503 - 503
12345